Page last updated: 2024-12-11

ozolinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ozolinone: active metabolite of etozolin; RN refers to (Z)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6436036
CHEMBL ID3989840
MeSH IDM0069367

Synonyms (46)

Synonym
56784-39-5
D05323
ozolinone (usan)
ozolinone [usan:inn]
ozolinone
ozolinono [inn-spanish]
w 3282
ozolinonum [inn-latin]
goedecke 3282
einecs 260-383-7
acetic acid, (3-methyl-4-oxo-5-(1-piperidinyl)-2-thiazolidinylidene)-, (z)-
ag 3282
(z)-3-methyl-4-oxo-5-piperidino-delta(sup 2,alpha)-thiazolidineacetic acid
(2z)-2-(3-methyl-4-oxo-5-piperidin-1-yl-1,3-thiazolidin-2-ylidene)acetic acid
ozolinonum
unii-55tit7j81d
55tit7j81d ,
ozolinono
AKOS022665309
(z)-3-methyl-4-oxo-5-piperidino-.delta.(sup 2,.alpha.)-thiazolidineacetic acid.
goedecke-382
ozolinone [inn]
(+/-)-ozolinone
(2z)-2-(3-methyl-4-oxo-5-(1-piperidinyl)-2-thiazolidinylidene)acetic acid
goedecke 382
ozolinone [usan]
acetic acid, 2-(3-methyl-4-oxo-5-(1-piperidinyl)-2-thiazolidinylidene)-, (2z)-
(2z)-[3-methyl-4-oxo-5-(1-piperidinyl)-1,3-thiazolidin-2-ylidene]ethanoic acid
unii-apr43352ov
unii-p8i697979q
(-)-ozolinone
acetic acid, (3-methyl-4-oxo-5-(1-piperidinyl)-2-thiazolidinylidene)-, (z)-(-)-
P8I697979Q ,
ozolinone, (+)-
acetic acid, (3-methyl-4-oxo-5-(1-piperidinyl)-2-thiazolidinylidene)-, (z)-(+)-
l-ozolinone
67565-42-8
67565-44-0
d-ozolinone
ozolinone, (-)-
APR43352OV ,
(+)-ozolinone
(z)-(3-methyl-4-oxo-5-piperidino-thiazolidin-2-ylidene) acetic acid
CHEMBL3989840
Q7116606
DTXSID30866590

Research Excerpts

Overview

Ozolinone is a loop diuretic with two isomers.

ExcerptReferenceRelevance
"Ozolinone is a loop diuretic with two isomers."( Effect of captopril on intrarenal blood flow.
Giesen, EM; Imbs, JL; Schmidt, M; Schwartz, J, 1984
)
0.99

Toxicity

ExcerptReferenceRelevance
" The method is based on the determination of the toxic dose (TD50) which causes a defined hearing loss in 50% of the animals tested."( Quantitative evaluation of ototoxic side effects of furosemide, piretanide, bumetanide, azosemide and ozolinone in the cat--a new approach to the problem of ototoxicity.
Göttl, KH; Klinke, R; Roesch, A, 1985
)
0.48

Dosage Studied

ExcerptRelevanceReference
" It is concluded that these changes in the kinetics of this lipophilic diuretic do not allow a reliable dosage regimen in patients with hepatic cirrhosis and ascites."( Altered kinetics of etozolin and its active metabolite ozolinone in hepatitis and hepatic cirrhosis with ascites.
Gerok, W; Knauf, H; Missmahl, M; Mutschler, E; Schölmerich, J, 1987
)
0.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (79.17)18.7374
1990's5 (20.83)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.01 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.00%)5.53%
Reviews1 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (92.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]